Zhigui Guo

机构：Affiliated Hospital of Hebei University · ORCID：0009-0007-2722-568X

发表论文 8 篇 · 总被引 177 次 · h-index 5

代表论文

• Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models (2016 · Journal of Hematology & Oncology · 被引 79)
• Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30 (2016 · Cancer Science · 被引 36)
• Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma (2020 · The FASEB Journal · 被引 27)
• HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma (2015 · Tumor Biology · 被引 26)
• Differential response to immunotherapy in different lesions of MSI-H double primary colorectal cancer: a case report and literature review (2024 · AME Case Reports · 被引 8)
• [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis]. (2017 · PubMed · 被引 1)